Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical predictors of treatment outcome in adult Tuberculous Meningitis patients at the Kundiawa General Hospital

Stanley Aiwara Jnr, Isi H. Kevau, David Linge, View ORCID ProfileIzzard Aglua
doi: https://doi.org/10.1101/2022.09.03.22279565
Stanley Aiwara Jnr
1Port Moresby General Hospital
Roles: Internal Medicine Registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isi H. Kevau
2Internal Medicine Department. Port Moresby General Hospital
Roles: Professor in Cardiology & Specialist Physician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Linge
3Port Moresby General Hospital
Roles: Professor in Internal Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Izzard Aglua
4Sir Joseph Nombri Memorial-Kundiawa General Hospital
Roles: Internal Medicine Registrar & Clinical Research Coordinator
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Izzard Aglua
  • For correspondence: izzard.agua@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Tuberculous meningitis is the most severe form of extrapulmonary TB and accounted for 5 % of 10 million TB cases globally in the WHO 2018 report, with mortality as high as 19.35% in children and 30% in adults. Clinicians in resource-poor settings are often challenged with limited diagnostic and therapeutic options for optimal patient care, and often rely on clinical parameters for diagnosis, treatment, monitoring and outcome prediction.

Aim This study was done to identify potential clinical predictors of i) length of in-hospital stay, and ii) death or discharge at 28 days, amongst Melanesian adults with TB meningitis at the Kundiawa General Hospital in Simbu Province of Papua New Guinea.

Method A retrospective observational study was conducted on 65 Melanesian adults with TB meningitis at the Kundiawa General Hospital in Simbu province between 2015 and 2019.

Result High case fatality (48%) and mortality rates (2.22 per 100,000 per year) for TB Meningitis in this study. Even higher case fatality of 90.9% with HIV co-infection. Parameters associated with higher 28-day mortality included admission GCS (P=0.039, 95% CI), HIV-TBM co-infection (P=0.049, 95% CI), positive fluid balance 24 hours after admission (P=0.061, 95% CI) and male gender (P=0.057, 95% CI).

Conclusion Study showed high case fatality (48%) and mortality rates (2.22 per 100,000 per year) for adult TB Meningitis, with even higher case fatality (90.9%) for HIV-TB co-infection. Admission GCS, positive fluid balance 24 hours after admission, HIV-TB co-infection and male gender were associated with higher 28-day mortality.

Background

Tuberculous meningitis (TBM) is the most severe form of extrapulmonary Tuberculosis (TB) and accounted for up to 5 % of 10 million TB cases reported globally by WHO in 2018, with a high mortality and morbidity 1, 2. TB meningitis studies have reported mortalities as a high as 19.35% in children and 30% in adults, with an associated high burden of neurological disability after treatment 3-5. Mortality was as high as 80% in studies from Sub-Saharan Africa and Asia 5.

The ongoing challenge for effective treatment with optimal outcome is further compounded in resource-poor settings in which clinicians are often faced with limited diagnostic and therapeutic options that impede timely and appropriate treatment 6-7. Clinicians often rely on clinical parameters for diagnosis, treatment, monitoring and outcome, to inform management decisions as well as discussions on disease condition and likely outcome with patients and relatives.

This observational study was therefore done to explore the role of certain clinical and cerebrospinal fluid (CSF) parameters in predicting treatment outcome amongst Melanesian adults with TB Meningitis at the Simbu Provincial Hospital in Papua New Guinea. The primary outcome measure assessed was death or discharge at 28 days, with length-of-hospitalization as the secondary outcome measure. Potential predictors of outcome assessed included duration of illness, duration of TB treatment, admission Glasgow Coma Score (GCS), mean arterial pressure (MAP) and plasma sodium on admission, fluid balance status 24 hours after admission, HIV-TBM co-infection and CSF findings (polymorphs, lymphocytes and acid-fast bacilli [AFB]), besides age and gender8, 9.

Aim

To identify potential clinical predictors of i) length of in-hospital stay, and ii) death or discharge at 28 days, amongst Melanesian adults with TB meningitis at the Kundiawa General Hospital in Simbu Province.

Method

A retrospective observational study was conducted on a total of 65 Melanesian adults with TB meningitis at the medical ward of the Sir Joseph Nombri Memorial, Kundiawa General Hospital in Simbu province between 2015 and 2019.

A modified Thwaites Criteria using clinical, radiological and CSF findings was employed for the diagnosis of Tuberculous Meningitis 10, 11, whereby a patient with at least four of the following thematic features was diagnosed as a case of TBM:

i) meningitis symptoms (headache, fever, photophobia, vomiting, fitting) ≥ 2 weeks, ii) personal or family history or symptoms of TB, iii) neck stiffness ± Kernig’s or Brudzinski’s sign, iv) altered conscious status, v) focal neurological symptoms, vi) regional lymphadenopathy or other extrapulmonary TB features, vii) consistent chest radiograph and viii) CSF findings (AFB positive, lymphocyte predominance, elevated glucose with low protein). Of the four diagnostic features, at least one of TB and one of meningitis was required to make a TB meningitis diagnosis. Focal neurological symptoms included cranial nerve palsies and CSF AFB was assessed by polymerase chain reaction (PCR).

Study data was collected retrospectively from admission notes in patients’ information chart using a semi-structured document review form by one investigator at a monthly interval over a 5-year period. Raw data was entered onto an excel spread sheet and imported into Stata 15.1 for analysis. Summary statistics and multivariate regression analysis were performed on variables of interest for possible relationships between predictor and outcome variables. Logistic regression was applied for 28-day mortality given its dichotomous nature, whilst liner regression was applied for length of in-hospital stay as it is numerical. The primary outcome measure assessed was death or discharge at 28 days, with length-of-hospitalization as the secondary outcome measure. Parameters assessed included duration of illness (days), duration of TB treatment (days), admission Glasgow Coma Score (GCS), mean arterial pressure (MAP) and plasma sodium on admission, fluid balance status 24 hours after admission, HIV-TBM co-infection and CSF findings (polymorphs, lymphocytes and acid-fast bacilli [AFB]), besides age and gender 8, 9. The retrospective nature of the study limited its ability to effectively asses neurological deficit (neuro-motor, cognitive) as an outcome measure, owing to data insufficiency.

65 patients, over 13 years of age and diagnosed with TB meningitis (per criteria) with or without HIV infection were included for this study. All study subjects received a course of dexamethasone (2-8 mg iv/oral/NGT) during in-hospital treatment.

Results

Death at 28 days

Case fatality for TB meningitis was 31/65, 48%

Mortality rate ∼2.22 per 100,000 adults per year in the province as at 2019 population data. Estimated adult population in Simbu province at 2019 was 278, 971 (2011 census data: total provincial population 376 973, 37% children under 15, and population growth rate 2.2% for PNG) 12.

For an estimated population of 400,000 adults, 9 would have died from TB meningitis every year, at the given mortality rate of 2.22 per 100,000 per year, for the 5-year study period.

Predictors of death or discharge at 28 days

Logistic regression for age, gender, duration of illness, duration of TB treatment, length of hospitalization, HIV-TBM co-infection, admission GCS, admission MAP, admission sodium, fluid balance status 24 hours after admission, CSF polymorphs, lymphocytes and positive AFB (PCR) on death at 28 days was performed.

Length of in-hospital stay

1 day to 473 days. 50% < 28 days, 90% < 60days. Mean admission duration of 36.62 days.

Predictors of length of in-hospital stay

Discussion

The high case fatality (48%) and mortality rates (2.22 per 100,000 per year) for TB Meningitis in this study concur with similar studies from resource-constrained settings around the world 13-15. Apart from the diagnostic and therapeutic limitations, parameters inherent to the biology of mycobacterium tuberculosis including virulence and persistence, together with the site and nature of disease condition, may account for similar higher mortalities for TB meningitis observed even in resource-rich settings 16-18.

At the estimated mortality rate of 2.22 per 100,000 adults per year in the province, 9 adults would have died from TB meningitis every year for a population of around 400,000 adults for the 5-year study period in the province.

The clinical parameters associated with 28-day mortality from this study were admission GCS, HIV-TBM co-infection, positive fluid balance status in the first 24 hours of treatment and male gender.

A multivariate regression analysis (Table 1) showed a statistically significant association between admission GCS (P=0.039, 95% CI), male gender (P=0.057, 95% CI) and 28-day mortality after controlling for possible confounders. The strength of the association between the predictor and outcome variables was however weak (R2=0.3108) in the model, owing largely to the small sample size (65), and therefore limiting the ability of the study to conclusively quantify the observed associations in terms of the relevant measure of association in odds ratio (OR). Hence, whilst it may be statistically sound to state that there were observed associations between predictor and outcomes variables of interest, any meaningful discussion of the OR (strength of these associations) is limited. A regression coefficient of R2 = 0.31 in the model means that a unit change in any of the predictor variables will entail only a 31% corresponding change in the outcome variable (28-day mortality), which is far less than at least 75% (R2 ≥ 0.75) which is deemed necessary to represent a reliably strong association between predictor and outcome variables. Therefore, larger, prospective cohort studies (RCT) would be ideal to further explore and clearly ascertain the potential associations observed in this study.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1. showing result from multi-variate regression analysis on outcome indicators for death at 28 days.

55.4% of study subjects had a GCS of 13 or lower on admission, which inadvertently affected their progress on treatment and subsequent outcome of higher mortality at 28 days. Depressed conscious status has long been identified as an independent prognostic factor for poor outcomes in TB, and other forms of chronic meningitis around the world 19. Delayed presentation to health care facilities with late treatment initiation continue to contribute to disease severity on admission, as reflected in this study by a high proportion of patients with lower admission GCS, and with subsequent poor outcomes in developing countries 20, 21.

The marginally significant association between positive fluid balance (P=0.061, 95% CI) 24 hours after admission and 28-day mortality observed, after controlling for confounding, highlights the role of fluid and electrolyte balance in treatment outcomes. A positive fluid balance after 24 hours of treatment was observed in only 25% of the study subjects but was significantly associated with higher mortality at 28 days, which warrants a closer attention by clinicians to fluid and electrolytes status during in-patient treatment of patients with TB meningitis and associated raised intracranial pressures 22, 23. TB Meningitis and raised intracranial pressure can cause syndromes of salt wasting or excess anti-diuretic hormone action (SIADH) with resulting hyponatremia which in-turn entails functional neurological derangement with poor outcomes 24-27.

TBM-HIV Co-infection is another independent predictor of mortality reported in several similar studies, with higher mortalities compared to non-HIV subjects with TB meningitis 28-30. The co-infection rate in this study was relatively low at 16.92% but with a significantly high case fatality of 90.9%. There was no statistically significant association between HIV-TBM co-infection (P=0.199, 95% CI) and 28-day mortality in the multivariate regression after controlling for other variables (Table 1). However, in the model regressing identified predictors (admission GCS, gender, fluid balance 24 hours after admission and HIV-TB con-infection) in table 2, there was a statistically significant association between HIV-TBM co-infection and 28-day mortality (P=0.049, 95% CI). This disparity may be attributable to potential confounding and/or underpowering of the study owing to the small sample size of 65 (type 2 error).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2. showing result from regression analysis for admission GCS, HIV-TBM coinfection, male gender and fluid balance 24 hours after admission on 28-day mortality.

The duration of hospitalization ranged from 1 to 473 days, with a mean duration of 36.62 days. 90% of subjects stayed more than two weeks but less than 60 days (2 months) in the hospital, which is characteristic of chronic diseases and highlights the challenge of considerations in longer in-hospital care.

In the regression model for identified predictors (Table 5), there was a weak (R2=0.25) but statistically significant association between positive CSF AFB (P=0.000, 95% CI), TBM-HIV Co-infection (P=0.036, 955 CI), positive fluid balance (P=0.036, 95% CI) and length of in-hospital stay after controlling for each other. Again, this may be attributable to confounding and the small sample size.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3. Summary of Predictor Variables for 28-day Mortality
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4. summary statistics for duration of hospitalization.
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 5. shows results from multivariate linear regerssion for potential determinants of duration of in-hospital stay.

The weak associations observed in regression models (R2 < 0.75) limit the value of assessed parameters as reliable predictors of length of hospitalization.

Conclusion

This study showed a relatively high case fatality (48%) and mortality rates (2.22 per 100,000 per year) for TB Meningitis amongst Melanesian adults admitted to the Kundiawa General Hospital. The case fatality for HIV-infected individuals with TB meningitis was much higher at 90.9%. Ninety percent of the subjects stayed for more than 2 weeks but less than 2 months in the hospital.

Admission GCS, positive fluid balance 24 hours after admission, HIV-TB co-infection and male gender were associated with higher 28-day mortality, and therefore can serve as useful clinical predictors of mortality in the care of TB meningitis patients, especially in resource-constrained settings. A positive CSF AFB can also serve as a useful indicator for duration of hospitalization amongst TB meningitis patients.

Prospective cohort studies with larger sample sizes are needed to further explore and ascertain the associations observed in this study.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Ethics

Ethical consideration and approval was granted by the interim Institutional Review Committee of the SiPHA-Clinical Research Center.

Acknowledgement

I would like to extend a sincere thank you to individuals and institutions without whose help and support this study would not have been possible, including:

  • My spouse and colleague Dr. Jacqueline Pahun

  • Sir Joseph Nombri Memorial-Kundiawa General Hospital administration and ward staff: Dr. Francis Wandi, Dr. Raymond Saulep, Dr. Cassius Maingu, Dr. Kassi Ken, Dr. Izzard Agua, Sr. Moro Drua and the nursing staff.

  • Internal Medicine Department, UPNG SMHS & PGMH: Dr. Alexander Maha, Prof. David Linge, Prof. Sir Isi. H. Kevau.

Abbreviations

TBM
Tuberculous Meningitis
TB
Tuberculosis
WHO
World Health Organization
GCS
Glasgow Coma Scale
CSF
Cerebrospinal Fluid
PCR
Polymerase Chain Reaction
CI
Confidence Interval
AFB
Acid Fast Bacilli
NGT
Nasogastric Tube
SiPHA
Simbu Provincial Health Authority.

References

  1. 1.↵
    World Health Organization, 2014. World Health Organization Global Tuberculosis Report 2013.
  2. 2.↵
    Thao, L.T.P., Heemskerk, A.D., Geskus, R.B., Mai, N.T.H., Ha, D.T.M., Chau, T.T.H., Phu, N.H., Chau, N.V.V., Caws, M., Lan, N.H. and Thu, D.D.A., 2018. Prognostic models for 9-month mortality in tuberculous meningitis. Clinical Infectious Diseases, 66(4), pp.523–532.
    OpenUrlCrossRef
  3. 3.↵
    Chiang, S.S., Khan, F.A., Milstein, M.B., Tolman, A.W., Benedetti, A., Starke, J.R. and Becerra, M.C., 2014. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. The Lancet Infectious Diseases, 14(10), pp.947–957.
    OpenUrlCrossRefPubMed
  4. 4.
    Thwaites, G.E. and Hien, T.T., 2005. Tuberculous meningitis: many questions, too few answers. The Lancet Neurology, 4(3), pp.160–170.
    OpenUrl
  5. 5.↵
    Stadelman, A.M., Ellis, J., Samuels, T.H., Mutengesa, E., Dobbin, J., Ssebambulidde, K., Rutakingirwa, M.K., Tugume, L., Boulware, D.R., Grint, D. and Cresswell, F.V., 2020, August. Treatment outcomes in adult tuberculous meningitis: a systematic review and meta-analysis. In Open forum infectious diseases (Vol. 7, No. 8, p. ofaa257). US: Oxford University Press.
    OpenUrl
  6. 6.↵
    World Health Organization, 2007. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings (No. WHO/HTM/TB/2007.379). World Health Organization.
  7. 7.↵
    Getahun, H., Harrington, M., O’Brien, R. and Nunn, P., 2007. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. The Lancet, 369(9578), pp.2042–2049.
    OpenUrl
  8. 8.↵
    Wen, L., Li, M., Xu, T., Yu, X., Wang, L. and Li, K., 2019. Clinical features, outcomes and prognostic factors of tuberculous meningitis in adults worldwide: systematic review and meta-analysis. Journal of neurology, 266(12), pp.3009–3021.
    OpenUrl
  9. 9.↵
    Li, K., Tang, H., Yang, Y., Li, Q., Zhou, Y., Ren, M., Long, X., Shen, W., Hu, R., Wang, X. and Zeng, K., 2017. Clinical features, long-term clinical outcomes, and prognostic factors of tuberculous meningitis in West China: a multivariate analysis of 154 adults. Expert review of anti-infective therapy, 15(6), pp.629–635.
    OpenUrl
  10. 10.↵
    Sunbul, M., Atilla, A., Esen, S., Eroglu, C. and Leblebicioglu, H., 2005. Thwaites’ diagnostic scoring and the prediction of tuberculous meningitis. Medical Principles and Practice, 14(3), pp.151–154.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Thwaites, G.E., Bang, N.D., Dung, N.H., Quy, H.T., Oanh, D.T.T., Thoa, N.T.C., Hien, N.Q., Thuc, N.T., Hai, N.N., Lan, N.T.N. and Lan, N.N., 2004. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New England Journal of Medicine, 351(17), pp.1741–1751.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Allen, B., 2014. Papua New Guinea national census 2011: Rates of population change in local level government areas.
  13. 13.↵
    Soria, J., Metcalf, T., Mori, N., Newby, R.E., Montano, S.M., Huaroto, L., Ticona, E. and Zunt, J.R., 2019. Mortality in hospitalized patients with tuberculous meningitis. BMC infectious diseases, 19(1), pp.1–7.
    OpenUrlCrossRef
  14. 14.
    Hosoglu, S., Geyik M F., Balik, I., Aygen, B., Erol, S., Aygencel T, G., Mert, A., Saltoglu, N., Dokmetas, I., Felek, S. and Sunbul, M., 2002. Predictors of outcome in patients with tuberculous meningitis. The International Journal of Tuberculosis and Lung Disease, 6(1), pp.64–70.
    OpenUrl
  15. 15.↵
    Woldeamanuel, Y.W. and Girma, B., 2014. A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa. Journal of neurology, 261(5), pp.851–865.
    OpenUrl
  16. 16.↵
    Smith, I., 2003. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical microbiology reviews, 16(3), pp.463–496.
    OpenUrlAbstract/FREE Full Text
  17. 17.
    Davis, A.G., Rohlwink, U.K., Proust, A., Figaji, A.A. and Wilkinson, R.J., 2019. The pathogenesis of tuberculous meningitis. Journal of leukocyte biology, 105(2), pp.267–280.
    OpenUrlCrossRef
  18. 18.↵
    Thee, S., Basu Roy, R., Blázquez-Gamero, D., Falcón-Neyra, L., Neth, O., Noguera-Julian, A., Lillo, C., Galli, L., Venturini, E., Buonsenso, D. and Götzinger, F., 2021. Treatment and Outcome in Children with Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study. Clinical Infectious Diseases.
  19. 19.↵
    Yasar, K.K., Pehlivanoglu, F. and Sengoz, G., 2010. Predictors of mortality in tuberculous meningitis: a multivariate analysis of 160 cases. The International journal of tuberculosis and lung disease, 14(10), pp.1330–1335.
    OpenUrl
  20. 20.↵
    Nataprawira, H.M., Ruslianti, V., Solek, P., Hawani, D., Milanti, M., Anggraeni, R., Memed, F.S. and Kartika, A., 2016. Outcome of tuberculous meningitis in children: the first comprehensive retrospective cohort study in Indonesia. The International Journal of Tuberculosis and Lung Disease, 20(7), pp.909–914.
    OpenUrl
  21. 21.↵
    Sheu, J.J., Yuan, R.Y. and Yang, C.C., 2009. Predictors for outcome and treatment delay in patients with tuberculous meningitis. The American journal of the medical sciences, 338(2), pp.134–139.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Brancusi, F., Farrar, J. and Heemskerk, D., 2012. Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future microbiology, 7(9), pp.1101–1116.
    OpenUrl
  23. 23.↵
    Donovan, J., Rohlwink, U.K., Tucker, E.W., Hiep, N.T.T., Thwaites, G.E., Figaji, A.A. and Tuberculous Meningitis International Research Consortium, 2019. Checklists to guide the supportive and critical care of tuberculous meningitis. Wellcome Open Research, 4.
  24. 24.↵
    Harrigan, M.R., 2001. Cerebral salt wasting syndrome. Critical care clinics, 17(1), pp.125–138.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.
    Ganong, C.A. and Kappy, M.S., 1993. Cerebral salt wasting in children: the need for recognition and treatment. American Journal of Diseases of Children, 147(2), pp.167–169.
    OpenUrlCrossRefPubMed
  26. 26.
    Palmer, B.F., 2003. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends in Endocrinology & Metabolism, 14(4), pp.182–187.
    OpenUrl
  27. 27.↵
    Cotton, M.F., Donald, P.R., Schoeman, J.F., Van Zyl, L.E., Aalbers, C. and Lombard, C.J., 1993. Raised intracranial pressure, the syndrome of inappropriate antidiuretic hormone secretion, and arginine vasopressin in tuberculous meningitis. Child’s Nervous System, 9(1), pp.10–15.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    Garg, R.K. and Sinha, M.K., 2011. Tuberculous meningitis in patients infected with human immunodeficiency virus. Journal of neurology, 258(1), pp.3–13.
    OpenUrlCrossRefPubMed
  29. 29.
    Thinyane, K.H., Motsemme, K.M. and Cooper, V.J.L., 2015. Clinical presentation, aetiology, and outcomes of meningitis in a setting of high HIV and TB prevalence. Journal of tropical medicine, 2015.
  30. 30.↵
    Cecchini, D., Ambrosioni, J., Brezzo, C., Corti, M., Rybko, A., Perez, M., Poggi, S. and Ambroggi, M., 2009. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. The International Journal of Tuberculosis and Lung Disease, 13(2), pp.269–271.
    OpenUrl
Back to top
PreviousNext
Posted September 04, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical predictors of treatment outcome in adult Tuberculous Meningitis patients at the Kundiawa General Hospital
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical predictors of treatment outcome in adult Tuberculous Meningitis patients at the Kundiawa General Hospital
Stanley Aiwara Jnr, Isi H. Kevau, David Linge, Izzard Aglua
medRxiv 2022.09.03.22279565; doi: https://doi.org/10.1101/2022.09.03.22279565
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Clinical predictors of treatment outcome in adult Tuberculous Meningitis patients at the Kundiawa General Hospital
Stanley Aiwara Jnr, Isi H. Kevau, David Linge, Izzard Aglua
medRxiv 2022.09.03.22279565; doi: https://doi.org/10.1101/2022.09.03.22279565

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1240)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10023)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2281)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4834)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)